David Christopher Horwell

This inventor holds 63 USPTO granted patents and 3 published patent applications and 1 EPO patent, primarily in Pharmaceutical Agents (CPC class 5144). Top assignees: Warner-Lambert Company, Pfizer Corporation, Merck Sharp + Dohme Corp.. Active years: 1986-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Christopher Horwell. Retrieved from https://idiyas.com/inventor/david-christopher-horwell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 63 (Patent Applications = 3)

% Patents Active = 92.1

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 2.7

ph-index = 17

Forward Citations = 800(Granted Patents)

Forward Citations (Not Self Cited) = 756(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Foxton, Cambridge, GB (1996)
Foxton, GB (1986 - 2000)
Cambridge, GB (1986 - 2006)

Company Filing History:

57 out of 2,538

Warner-Lambert Company

Merck Sharp + Dohme Corp.

5. 1 out of 834,453

Other

patents

Years Active: 1986-2006

Loading Chart...

Areas of Expertise:

Cyclic Amino Acids

Pharmaceutical Agents

Tachykinin Antagonists

Gabapentin Analogues

Cholecystokinin Antagonists

Conformationally Constrained Compounds

Branched Alkyl Pyrrolidine

Non-Peptide Compounds

Dendritic Compounds

Selective K-Agonists

Neurological Disorders

Pain Treatment

63 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7122678 - Cyclic amino acids and derivatives thereof useful as pharmaceutical agents (2006-10-17),

2. 6921835 - Cyclic amino acids and derivatives thereof useful as pharmaceutical agents (2005-07-26),

3. 6846953 - Aromatic amides (2005-01-25),

4. 6635673 - Cyclic amino acids and derivatives thereof useful as pharmaceutical agents (2003-10-21),

5. 6545022 - 4(3)substituted-4(3)-aminomethyl-(thio)pyran or piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders (2003-04-08),

6. 6521650 - Amines as pharmaceutical agents (2003-02-18),

7. 6518289 - 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders (2003-02-11),

8. 6489352 - Conformationally constrained compounds as pharmaceutical agents (2002-12-03),

9. 6472418 - Non-peptide NK1 receptors antagonists (2002-10-29),

10. 6316638 - Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel (2001-11-13),

11. 6245801 - Branched alkyl pyrrolidine-3-carboxylic acids (2001-06-12),

12. 6225352 - Low molecular weight dendritic compounds as pharmaceutical agents (2001-05-01),

13. 6194437 - Non-peptide bombesin receptor antagonists (2001-02-27),

14. 6153650 - Substituted gamma aminobutyric acids as pharmaceutical agents (2000-11-28),

15. 6133307 - Certain benzofuranyl-N-[pyrrolidin-1-YL]-N-methyl-acetamide derivatives (2000-10-17),

Title: The Innovative Mind of David Christopher Horwell

Introduction: David Christopher Horwell, a distinguished inventor hailing from Cambridge, GB, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: David Horwell's recent patents showcase his expertise in developing cutting-edge solutions for various industries, including artificial intelligence, renewable energy, and healthcare.

Career Highlights: With a career spanning over two decades, David Horwell has established himself as a visionary inventor with a keen eye for identifying gaps in the market and creating innovative solutions to address them. His work has revolutionized multiple sectors, earning him accolades and recognition globally.

Collaborations: Throughout his career, David Horwell has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: In conclusion, David Christopher Horwell's relentless passion for innovation and his remarkable problem-solving skills have solidified his position as a trailblazing inventor in the realm of technology. His contributions continue to inspire future generations of inventors and shape the landscape of innovation worldwide.

Profile summary based on public USPTO records.